Diabetes medications with cardiovascular protection in the wake of EMPA-REG OUTCOME: the optimal combination may be metformin, pioglitazone and empagliflozin (and liraglutide?)

Related Event
ABCD Spring Meeting 2016

File(s)

Diabetes medications with cardiovascular protection in the wake of EMPA-REG OUTCOME: the optimal combination may be metformin, p

Discipline

Diabetes

Resource taxonomy

Event resources Slides

Clinical taxonomy

Cardiovascular Treatments for diabetes Type 2 diabetes mellitus

Listing status